bf/NYSE:BMY_icon.jpeg

NYSE:BMY

Bristol Myers Squibb

  • Stock

49.61

−1.18%

1.42

USD last updated 19/08 01:34:24

Last Close

48.19

18/08 22:30

Market Cap

100.98B

Beta: 0.43

Volume Today

17.16M

Avg: 7.82M

PE Ratio

11.94

PFCF: 8.37

Dividend Yield

4.80%

Payout:57.08%

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    0.511.522017-07-272019-07-252021-07-282023-07-272025-02-07

    Revenue (Estimate*)

    2B4B6B8B10B12B2017-07-272019-07-252021-07-282023-07-272025-02-07

    *Estimate based on analyst consensus